most likely some nervous shorts trying to cover, with asco and partnership in the works...they know time is almost over for them...
Time to show the shorts who is in charge, even if you only buy 50 shares just start
buying tomorrow at the open....
If the second study is also successful, CTI Biopharma and its partner Baxter have told investors that they will seek regulatory approval for pacritinib before the end of the year. what more could one want as an investor
the next 30 days, expect Funds to pile in more cash, shorts to follow behind, don't be left out
don't be left out or short....stay short is better for us longs here......
I hope they don't cover, funds and investors are buyers here, let the shorts come in last....
SHOULD TRIPLE FROM HERE
soon could see double digits
None of the patients treated in the control arm became transfusion independent.
can you say $6 a coming fast
Sentiment: Strong Buy
Awesome data, large funds will flock like locoust...$$$$$$$$
Did someone leak out the info here, or is this a hedge working for a clients bid for the company?
either way should be good for the share holders unless the offer is low like $5 or $6